Skip to Content

Health

Lack of equity within priority groups leaves Covid-19’s most vulnerable without vaccine, analysis suggests

As demand for Covid-19 vaccines continues to outpace supply, there’s still not sufficient supply to cover everyone within even the top priority groups. But by targeting vaccine distribution to more specific vulnerable populations, states could have the opportunity to save thousands of lives and prevent even more hospitalizations, according to a new analysis. Around the

Continue Reading

FDA says Johnson & Johnson Covid-19 vaccine meets requirements for emergency use authorization

In an analysis released Wednesday, the US Food and Drug Administration said the Johnson & Johnson Covid-19 vaccine has met the requirements for emergency use authorization. The efficacy of the Johnson & Johnson vaccine against moderate to severe/critical Covid-19 across all geographic areas was 66.9% at least 14 days after the single dose vaccination and

Continue Reading

Experts worry variant-fueled surge of Covid-19 could be weeks away but cases will likely fall again by summer

Coronavirus infections across the US are still on the way down, and more Americans are getting vaccinated — but variants could cause complications soon. Several experts predicted Tuesday the highly contagious B.1.1.7 variant first detected in the UK is likely to fuel another surge of cases in just a matter of weeks. “It could result

Continue Reading
Skip to content